Sunday, 5 October 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 05 October 2025
News

Pfizer cuts drug prices in Trump deal

Posted 1 October 2025 AM 

Pfizer is first off the bat to make a deal with the US Government to lower the price of the drugs it sells to Medicaid, as America tries to "retrain" other countries to pay higher prices.

Pfizer CEO Albert Bourla joined US President Donald Trump and other high-ranking health officials in the Oval Office to announce the deal, arguably the biggest win for Trump in his second term - and one that could have a drastic impact on access to medicines in Australia.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (25)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (2)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.